BAX
Baxter International Inc. (NYSE)
Delayed quote data
11/28/2014 02:08 PM
hide quote detailed quote options chain chart help
Last:
73.00
Change:
arrow +0.60
Open:
72.82
High:
73.20
Low:
72.65
Volume:
1,160,271
Percent Change:
+0.83%
Yield:
2.85%
P/E Ratio:
21.2246
52 Week Range:
65.53 to 77.31
01:00 AM ET

Headlines for Baxter International Inc. (NYSE:BAX)

News for Baxter International Inc.

  1. Thursday, October 16, 2014

    1. 07:44 AM ET

      Baxter profit down, but tops expectations MarketWatch

    2. 07:35 AM ET

      Baxter’s Medical-Products Sales Rise The Wall Street Journal Interactive Edition

  2. Tuesday, September 30, 2014

    1. 07:30 PM ET

      Bosses More Flexible About Relocation The Wall Street Journal Interactive Edition

  3. Wednesday, September 24, 2014

    1. 07:54 AM ET

      Merrimack Pharma shares surge on licensing pact with Baxter MarketWatch

    2. 07:43 AM ET

      Baxter, Merrimack to Collaborate on Pancreatic Cancer Drug The Wall Street Journal Interactive Edition

  4. Monday, August 18, 2014

    1. 04:50 PM ET

      Risks Create Tumult for Tech, Health-Care Firms The Wall Street Journal Interactive Edition

  5. Tuesday, August 12, 2014

    1. 10:42 PM ET

      CSL Weighs New Stock Buyback The Wall Street Journal Interactive Edition

    2. 07:35 PM ET

      Australia's CSL considers bigger stock buyback MarketWatch

  6. Wednesday, July 30, 2014

    1. 08:33 AM ET

      Pfizer to buy Baxter’s vaccines for $635 million MarketWatch

    2. 08:19 AM ET

      Pfizer To Buy Baxter's Vaccines The Wall Street Journal Interactive Edition

More

Company Releases for Baxter International Inc.

  1. Wednesday, November 19, 2014

    1. 08:01 AM ET

      Merrimack Pharmaceuticals Receives FDA Fast Track Designation for MM-398 in Post-Gemcitabine Metastatic Pancreatic Cancer GlobeNewswire

  2. Thursday, November 13, 2014

    1. 04:16 PM ET

      Baxter to Present at the 26th Annual Piper Jaffray Healthcare Conference BusinessWire - BZX

  3. Tuesday, November 11, 2014

    1. 09:05 AM ET

      Baxter Declares Quarterly Dividend BusinessWire - BZX

  4. Thursday, November 06, 2014

    1. 08:31 AM ET

      Merrimack Pharmaceuticals Announces Initiation of Phase 1 Clinical Study of MM-398 for Brain Cancer GlobeNewswire

  5. Wednesday, November 05, 2014

    1. 04:15 PM ET

      Baxter to Present at the Stifel 2014 Healthcare Conference BusinessWire - BZX

  6. Tuesday, November 04, 2014

    1. 06:16 AM ET

      Life-Science New Build Report: 200 New North American Sites in Planning Represent Potential $15 Billion Investment, an Industrial Info News Alert Marketwired

  7. Monday, November 03, 2014

    1. 09:15 AM ET

      Upcoming Earnings, Financial Results, New Affiliations, and Study Results - Research Reports on Regeneron, Valeant, CVS Health, CIGNA and Baxter PR Newswire - PRF

  8. Thursday, October 30, 2014

    1. 09:02 AM ET

      Baxter’s Investigational 20% Subcutaneous Immunoglobulin Treatment Meets Efficacy and Tolerability Endpoints in Phase 2/3 Study BusinessWire - BZX

    2. 06:02 AM ET

      Pharmaceutical-Biotech Industry to Wrap Up Year With $4.5 Billion Investment in Fourth-Quarter 2014 Project Starts, an Industrial Info News Alert Marketwired

  9. Tuesday, October 28, 2014

    1. 08:35 AM ET

      Morning Analysis on Health Care Equipment Stocks - Zimmer Holdings, Edwards Lifesciences, Varian Medical Systems, CareFusion, and Baxter Intl. PR Newswire - PRF

More

Most recent headlines